These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37647711)

  • 21. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus.
    Banser A; Naafs JC; Hoorweg-Nijman JJ; van de Garde EM; van der Vorst MM
    Pediatr Diabetes; 2016 Sep; 17(6):426-32. PubMed ID: 26332801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin autofluorescence and peripheral neuropathy four years later in type 1 diabetes.
    Rajaobelina K; Farges B; Nov S; Maury E; Cephise-Velayoudom FL; Gin H; Helmer C; Rigalleau V
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27235334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study.
    Vélayoudom-Céphise FL; Rajaobelina K; Helmer C; Nov S; Pupier E; Blanco L; Hugo M; Farges B; Astrugue C; Gin H; Rigalleau V
    Cardiovasc Diabetol; 2016 Sep; 15(1):127. PubMed ID: 27585632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes.
    Boersma HE; van Waateringe RP; van der Klauw MM; Graaff R; Paterson AD; Smit AJ; Wolffenbuttel BHR
    BMC Endocr Disord; 2021 Jan; 21(1):14. PubMed ID: 33435948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin autofluorescence Is associated With low bone mineral density in type 2 diabetic patients.
    Yavuz DG; Apaydin T
    J Clin Densitom; 2022; 25(3):373-379. PubMed ID: 34933784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of diabetic foot ulcers with chronic vascular diabetic complications in patients with type 2 diabetes.
    Megallaa MH; Ismail AA; Zeitoun MH; Khalifa MS
    Diabetes Metab Syndr; 2019; 13(2):1287-1292. PubMed ID: 31336479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study.
    van Waateringe RP; Slagter SN; van der Klauw MM; van Vliet-Ostaptchouk JV; Graaff R; Paterson AD; Lutgers HL; Wolffenbuttel BH
    Eur J Clin Invest; 2016 May; 46(5):481-90. PubMed ID: 27002914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures.
    Alkhami F; Borderie G; Foussard N; Larroumet A; Blanco L; Barbet-Massin MA; Ferriere A; Ducos C; Mohammedi K; Fawaz S; Couffinhal T; Rigalleau V
    Cardiovasc Diabetol; 2024 Jan; 23(1):32. PubMed ID: 38218857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring of Advanced Glycation End Products in Acute Stroke Care: Skin Autofluorescence as a Predictor of Ischemic Stroke Outcome in Patients with Diabetes Mellitus.
    Filipov A; Fuchshuber H; Kraus J; Ebert AD; Sandikci V; Alonso A
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes.
    Bentata R; Cougnard-Grégoire A; Delyfer MN; Delcourt C; Blanco L; Pupier E; Rougier MB; Rajaobelina K; Hugo M; Korobelnik JF; Rigalleau V
    J Diabetes Complications; 2017 Mar; 31(3):619-623. PubMed ID: 28063765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components.
    van Waateringe RP; Slagter SN; van Beek AP; van der Klauw MM; van Vliet-Ostaptchouk JV; Graaff R; Paterson AD; Lutgers HL; Wolffenbuttel BHR
    Diabetol Metab Syndr; 2017; 9():42. PubMed ID: 28572855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for diabetic foot ulcers: an Albanian retrospective study of inpatients with type 2 diabetes.
    Pastore D; Deja-Simoni A; De Stefano A; Pacifici F; Cela E; Infante M; Coppola A; Di Daniele N; Lauro D; Della-Morte D; Donadel G
    Eur Rev Med Pharmacol Sci; 2022 Jan; 26(2):558-572. PubMed ID: 35113432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced glycation end products, measured as skin autofluorescence, during normal pregnancy and pregnancy complicated by diabetes mellitus.
    de Ranitz-Greven WL; Kaasenbrood L; Poucki WK; Hamerling J; Bos DC; Visser GH; Biesma DH; Beulens JW; de Valk HW
    Diabetes Technol Ther; 2012 Dec; 14(12):1134-9. PubMed ID: 23113747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between dietary and skin advanced glycation end products: the Rotterdam Study.
    Chen J; Waqas K; Tan RC; Voortman T; Ikram MA; Nijsten TEC; de Groot LCPGM; Uitterlinden AG; Zillikens MC
    Am J Clin Nutr; 2020 Jul; 112(1):129-137. PubMed ID: 32453418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin autofluorescence corresponds to microvascular reactivity in diabetes mellitus.
    Škrha J; Horová E; Šoupal J; Valeriánová A; Malík J; Prázný M; Zima T; Kalousová M; Škrha J
    J Diabetes Complications; 2022 Jul; 36(7):108206. PubMed ID: 35644724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic dysfunction-associated fatty liver disease in the elderly with diabetic foot ulcers: A longitudinal cohort study.
    Zhang L; Lin Y; Huang X; Zhai Z; Wei R; Mo J; Li J; Lu W
    Int Wound J; 2024 Apr; 21(4):e14586. PubMed ID: 38102851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
    Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
    Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of skin autofluorescence as a surrogate of advanced glycation end products accumulation in children and adolescents with normal haemoglobin A1c values.
    Jankowska M; Bobeff K; Baranowska-Jaźwiecka A; Mianowska M; Lubnauer A; Michalak A; Młynarski W; Szadkowska A; Mianowska B
    Pediatr Endocrinol Diabetes Metab; 2020; 26(1):1-9. PubMed ID: 32418416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between advanced glycation end products and ocular circulation in type 2 diabetes.
    Hashimoto K; Kunikata H; Yasuda M; Ito A; Aizawa N; Sawada S; Kondo K; Satake C; Takano Y; Nishiguchi KM; Katagiri H; Nakazawa T
    J Diabetes Complications; 2016; 30(7):1371-7. PubMed ID: 27209548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin advanced glycation end products in HIV infection are increased and predictive of development of cardiovascular events.
    Sprenger HG; Bierman WF; Martes MI; Graaff R; van der Werf TS; Smit AJ
    AIDS; 2017 Jan; 31(2):241-246. PubMed ID: 27763891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.